Literature DB >> 30689785

Central Mechanisms of Glucose Sensing and Counterregulation in Defense of Hypoglycemia.

Sarah Stanley1, Amir Moheet2, Elizabeth R Seaquist2.   

Abstract

Glucose homeostasis requires an organism to rapidly respond to changes in plasma glucose concentrations. Iatrogenic hypoglycemia as a result of treatment with insulin or sulfonylureas is the most common cause of hypoglycemia in humans and is generally only seen in patients with diabetes who take these medications. The first response to a fall in glucose is the detection of impending hypoglycemia by hypoglycemia-detecting sensors, including glucose-sensing neurons in the hypothalamus and other regions. This detection is then linked to a series of neural and hormonal responses that serve to prevent the fall in blood glucose and restore euglycemia. In this review, we discuss the current state of knowledge about central glucose sensing and how detection of a fall in glucose leads to the stimulation of counterregulatory hormone and behavior responses. We also review how diabetes and recurrent hypoglycemia impact glucose sensing and counterregulation, leading to development of impaired awareness of hypoglycemia in diabetes.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30689785      PMCID: PMC6505456          DOI: 10.1210/er.2018-00226

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  236 in total

Review 1.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

Authors:  Roger H Unger; Alan D Cherrington
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

2.  Blockade of GABA(A) receptors in the ventromedial hypothalamus further stimulates glucagon and sympathoadrenal but not the hypothalamo-pituitary-adrenal response to hypoglycemia.

Authors:  Owen Chan; Wanling Zhu; Yuyan Ding; Rory J McCrimmon; Robert S Sherwin
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

3.  Topographic localisation of insulinogenic and insulinoprival areas in the hypothalamus.

Authors:  S K Garg; G S Chhina; B Singh
Journal:  Experientia       Date:  1978-09-15

4.  Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats.

Authors:  M A Borg; R S Sherwin; W P Borg; W V Tamborlane; G I Shulman
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

5.  Brain glucose concentrations in patients with type 1 diabetes and hypoglycemia unawareness.

Authors:  Amy B Criego; Ivan Tkac; Anjali Kumar; William Thomas; Rolf Gruetter; Elizabeth R Seaquist
Journal:  J Neurosci Res       Date:  2005 Jan 1-15       Impact factor: 4.164

6.  Hypothalamic proopiomelanocortin neurons are glucose responsive and express K(ATP) channels.

Authors:  Nurhadi Ibrahim; Martha A Bosch; James L Smart; Jian Qiu; Marcelo Rubinstein; Oline K Rønnekleiv; Malcolm J Low; Martin J Kelly
Journal:  Endocrinology       Date:  2003-04       Impact factor: 4.736

7.  Contribution of parasympathetic muscarinic augmentation of insulin secretion to olanzapine-induced hyperinsulinemia.

Authors:  Michael R Rickels; Elys M Perez; Amy J Peleckis; Erica Alshehabi; Huong-Lan Nguyen; Darko Stefanovski; Karl Rickels; Karen L Teff
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-12-19       Impact factor: 4.310

8.  Glucokinase inhibitor glucosamine stimulates feeding and activates hypothalamic neuropeptide Y and orexin neurons.

Authors:  Ligang Zhou; Chen-Yu Yueh; Daniel D Lam; Jill Shaw; Mayowa Osundiji; Alastair S Garfield; Mark Evans; Lora K Heisler
Journal:  Behav Brain Res       Date:  2011-04-01       Impact factor: 3.332

9.  The medial amygdalar nucleus: a novel glucose-sensing region that modulates the counterregulatory response to hypoglycemia.

Authors:  Ligang Zhou; Nina Podolsky; Zhen Sang; Yuyan Ding; Xiaoning Fan; Qingchun Tong; Barry E Levin; Rory J McCrimmon
Journal:  Diabetes       Date:  2010-07-13       Impact factor: 9.461

10.  Optogenetic activation of leptin- and glucose-regulated GABAergic neurons in dorsomedial hypothalamus promotes food intake via inhibitory synaptic transmission to paraventricular nucleus of hypothalamus.

Authors:  Zesemdorj Otgon-Uul; Shigetomo Suyama; Hiroshi Onodera; Toshihiko Yada
Journal:  Mol Metab       Date:  2016-06-24       Impact factor: 7.422

View more
  21 in total

1.  β-Hydroxybutyrate Alleviates Low Glucose-Induced Apoptosis via Modulation of ROS-Mediated p38 MAPK Signaling.

Authors:  Cixia Li; Xuejun Chai; Jiarong Pan; Jian Huang; Yongji Wu; Yuhuan Xue; Wentai Zhou; Jiping Yang; Xiaoyan Zhu; Shanting Zhao
Journal:  J Mol Neurosci       Date:  2022-02-07       Impact factor: 3.444

2.  Altered Caffeine Metabolism Is Associated With Recurrent Hypoglycemia in Type 2 Diabetes Mellitus: A UPLC-MS-Based Untargeted Metabolomics Study.

Authors:  Wang Lijing; Ke Sujie; Wang Linxi; Huang Lishan; Qi Liqin; Zhan Zhidong; Wu Kejun; Zhang Mengjun; Liu Xiaoying; Liu Xiaohong; Liu Libin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-17       Impact factor: 6.055

Review 3.  Hypoglycemia-associated autonomic failure, counterregulatory responses, and therapeutic options in type 1 diabetes.

Authors:  Michael R Rickels
Journal:  Ann N Y Acad Sci       Date:  2019-08-06       Impact factor: 5.691

4.  The Characterization of Sex Differences in Hypoglycemia-Induced Activation of HPA Axis on the Transcriptomic Level.

Authors:  Serpil Taheri; Zuleyha Karaca; Minoo Rassoulzadegan; Ecmel Mehmetbeyoglu; Gokmen Zararsiz; Elif Funda Sener; Kezban Korkmaz Bayram; Esra Tufan; Mustafa Caglar Sahin; Mert Kahraman Marasli; Mehmet Memis; Halit Canatan; Figen Ozturk; Fatih Tanriverdi; Kursad Unluhizarci; Fahrettin Kelestimur
Journal:  Cell Mol Neurobiol       Date:  2021-02-05       Impact factor: 5.046

5.  Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes.

Authors:  Martha Campbell-Thompson; Elizabeth A Butterworth; J Lucas Boatwright; Malavika A Nair; Lith H Nasif; Kamal Nasif; Andy Y Revell; Alberto Riva; Clayton E Mathews; Ivan C Gerling; Desmond A Schatz; Mark A Atkinson
Journal:  Sci Rep       Date:  2021-03-22       Impact factor: 4.379

6.  A View on Pathogenesis of ≪Vicious Cancer Progression Cycle≫.

Authors:  Polina Schwartsburd
Journal:  Front Oncol       Date:  2020-04-30       Impact factor: 6.244

7.  Plasma Epinephrine Contributes to the Development of Experimental Hypoglycemia-Associated Autonomic Failure.

Authors:  Eric Lontchi-Yimagou; Sandra Aleksic; Raphael Hulkower; Rebekah Gospin; Akankasha Goyal; Bryan Kuo; William G Mitchell; Jee Young You; Laxmi Upadhyay; Michelle Carey; Oana A Sandu; Ilan Gabriely; Harry Shamoon; Meredith Hawkins
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

8.  Gut-brain communication by distinct sensory neurons differently controls feeding and glucose metabolism.

Authors:  Diba Borgmann; Elisa Ciglieri; Nasim Biglari; Claus Brandt; Anna Lena Cremer; Heiko Backes; Marc Tittgemeyer; F Thomas Wunderlich; Jens C Brüning; Henning Fenselau
Journal:  Cell Metab       Date:  2021-05-26       Impact factor: 27.287

9.  Effects of Gastric Bypass Surgery on the Brain: Simultaneous Assessment of Glucose Uptake, Blood Flow, Neural Activity, and Cognitive Function During Normo- and Hypoglycemia.

Authors:  Kristina E Almby; Martin H Lundqvist; Niclas Abrahamsson; Sofia Kvernby; Markus Fahlström; Maria J Pereira; Malin Gingnell; F Anders Karlsson; Giovanni Fanni; Magnus Sundbom; Urban Wiklund; Sven Haller; Mark Lubberink; Johan Wikström; Jan W Eriksson
Journal:  Diabetes       Date:  2021-03-04       Impact factor: 9.461

10.  Repeated hypoglycemia remodels neural inputs and disrupts mitochondrial function to blunt glucose-inhibited GHRH neuron responsiveness.

Authors:  Mitchell Bayne; Alexandra Alvarsson; Kavya Devarakonda; Rosemary Li; Maria Jimenez-Gonzalez; Darline Garibay; Kaetlyn Conner; Merina Varghese; Madhavika N Serasinghe; Jerry E Chipuk; Patrick R Hof; Sarah A Stanley
Journal:  JCI Insight       Date:  2020-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.